Emerging technology company chosen as the most innovative in clinical research at Disruptive Innovations 2016.

Atlanta, Ga-  Florence Healthcare, a software platform company focused on improving clinical trial site and sponsor collaboration, won the 2016 DPharm Idol competition in Boston last week.

Disruptive Innovations (DPharm) is an annual event that discusses solutions in clinical development, proposes innovative changes, and commits to testing and sharing the results in an effort to transform drug development.

The DPharm Idol competition encourages participating companies to showcase what they believe to be a disruptive clinical trial service or technology. Each DPharm Idol participant receives only a few minutes to highlight its clinical trial service or technology to a panel of judges. This year’s panel included innovation executives from GlaxoSmithKline, Janssen, Novartis Oncology, Bayer HealthCare, Biogen Idec, AstraZeneca and Eli Lilly & Company.

Florence featured its eBinder Suite, an application changing the way medicines are brought to market by automating key clinical research tasks for both trial site researchers and the pharmaceutical companies that sponsor them.

“We thought the solution that Florence has developed can make a difference and free up time for investigators, giving them more time to work with patients,” said DPharm Idol judge Andreas Koester, MD, PhD.

eBinders ultimately ensure clinical teams are able to spend more time helping patients and less time dealing with paperwork. Meanwhile, it speeds study time by enabling remote sponsor access for monitoring and queries.

“We’ve taken a different approach from most other clinical research technology companies—we start by helping trial sites,” said Florence CEO, Ryan Jones. “Our mission is to help the doctors and nurses working with patients, first. We’re honored to be recognized for this approach at this year’s DPharm.” Jones pointed out that Florence has grown at a rate of 80% month to month over the past year.

About Florence

Florence advances clinical research through software. The Florence eBinder Suite replaces paper investigator site files, trial master files and source binders with a shared platform. This shared platform approach makes remote monitoring of eRegulatory and eSource documents possible while giving sponsors real-time insights into study progress. Hundreds of sponsors and sites worldwide trust Florence eBinders to move past paper study roadblocks and enable new approaches to trial management. Florence is based in Atlanta, Georgia.info@florencehc.com